Jury Awards Ariad $65.2M In Lilly Patent Feud
In the latest development in a long-running legal battle, a federal jury has awarded at least $65.2 million to Ariad Pharmaceuticals Inc. after finding that Eli Lilly and Co.'s osteoporosis drug...To view the full article, register now.
Already a subscriber? Click here to view full article